Your session is about to expire
← Back to Search
Supporter-Targeted Intervention for Sexual Assault Survivors (CARE Trial)
CARE Trial Summary
This trial is testing whether a 2-session intervention called CARE can help improve supporters' ability to respond effectively to survivors of sexual assault. There are two versions of CARE being tested: one in which survivors and supporters attend both sessions together, and one in which supporters attend sessions alone.
CARE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCARE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CARE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can attend the first study session within 2 weeks after screening.You can have someone who is eligible and willing to support you during the study.I was sexually assaulted less than 10 weeks ago.You have regular contact with a person who has survived a certain condition at least once a week.I can speak and read either English or Spanish.You have high levels of symptoms related to Post Traumatic Stress Disorder (PTSD), as measured by a test called the Primary Care PTSD Screen, and score 2 or higher out of 5.I am 14 years old or older.You need a device that can use Zoom video conferencing.You can attend the first study session within two weeks of being screened.I can receive and complete surveys in private, without anyone else accessing my device or account.
- Group 1: Dyadic CARE
- Group 2: Waitlist Control
- Group 3: Supporter-Only CARE
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current capacity for participants in this experiment?
"Affirmative. According to clinicaltrials.gov, this research trial began in May 18th 2022 and is still recruiting participants as of the last update on May 26th 2022. 144 patients are required for enrollment across a single medical facility."
What is the intended outcome of this clinical experiment?
"The primary goal of this trial, assessed at Baseline and 90 minutes following the initial intervention session (average), is to gauge how well supporters understand appropriate helping behaviour. Secondary outcomes include a change in supporter depression levels three months post-baseline, survivor role impairment at 3 months post-baseline as measured by the Behavioral Activation for Depression Scale (BADS) subscale score, and survivor alcohol consumption hours per week over the past month according to data gathered from Daily Drinking Questionnaires."
Is enrollment still open for this medical experiment?
"That is correct. According to clinicaltrials.gov, this research study has an ongoing recruitment process that began on May 18th 2022 and was last updated on the 26th of the same month. The investigators are aiming for a total sample size of 144 individuals from one location."
Share this study with friends
Copy Link
Messenger